SyntheticMR Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 37

Employees

  • Stock Symbol
  • SYNT

Stock Symbol

  • Share Price
  • $2.61
  • (As of Friday Closing)

SyntheticMR General Information

Description

Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Decision/Risk Analysis
Stock Exchange
SAT
Corporate Office
  • Storgatan 11
  • 582 23 Linkoping
  • Sweden
+46 013-10 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SyntheticMR Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.61 $2.63 $1.55 - $3.26 $109M 41.7M 21.3K $0.02

SyntheticMR Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 108,317 108,317 131,006 275,416
Revenue 8,393 8,393 6,730 6,803
EBITDA 1,806 1,806 1,295 1,752
Net Income 942 942 580 920
Total Assets 14,305 14,305 12,216 6,723
Total Debt 126 126 218 22
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SyntheticMR Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SyntheticMR‘s full profile, request access.

Request a free trial

SyntheticMR Patents

SyntheticMR Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150177350-A1 Methods and systems for improved magnetic resonance acquisition Active 02-Jul-2012 000000000 0
US-10073156-B2 Methods and systems for improved magnetic resonance acquisition Active 02-Jul-2012 000000000 00
EP-2867689-B1 Methods and systems for improved magnetic resonance acquistion Active 02-Jul-2012 000000000
EP-2867689-A1 Methods and systems for improved magnetic resonance acquistion Active 02-Jul-2012 000000000
EP-2867689-A4 Methods and systems for improved magnetic resonance acquistion Active 02-Jul-2012 G01R33/50 0
To view SyntheticMR’s complete patent history, request access »

SyntheticMR Executive Team (9)

Name Title Board Seat Contact Info
Ulrik Harrysson Chief Executive Officer
Johanna Norén Chief Financial Officer & Head of Investor Relations
Marcel Warntjes Founder & Board Member
Markus Malmgren Chief Technology Officer
Kyle Frye Chief Commercial Officer
You’re viewing 5 of 9 executive team members. Get the full list »

SyntheticMR Board Members (4)

Name Representing Role Since
Johan Sedihn Self Chairman & Board Member 000 0000
Marcel Warntjes SyntheticMR Founder & Board Member 000 0000
You’re viewing 2 of 4 board members. Get the full list »

SyntheticMR Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SyntheticMR Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SyntheticMR‘s full profile, request access.

Request a free trial

SyntheticMR ESG

Risk Overview

Risk Rating

Updated November, 10, 2022

30.26 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,421

Rank

00.00

Percentile

Healthcare

Industry

00 of 645

Rank

00.00

Percentile

Medical Devices

Subindustry

00 of 228

Rank

00.00

Percentile

To view SyntheticMR’s complete esg history, request access »

SyntheticMR FAQs

  • When was SyntheticMR founded?

    SyntheticMR was founded in 2007.

  • Who is the founder of SyntheticMR?

    Marcel Warntjes is the founder of SyntheticMR.

  • Who is the CEO of SyntheticMR?

    Ulrik Harrysson is the CEO of SyntheticMR.

  • Where is SyntheticMR headquartered?

    SyntheticMR is headquartered in Linkoping, Sweden.

  • What is the size of SyntheticMR?

    SyntheticMR has 37 total employees.

  • What industry is SyntheticMR in?

    SyntheticMR’s primary industry is Decision/Risk Analysis.

  • Is SyntheticMR a private or public company?

    SyntheticMR is a Public company.

  • What is SyntheticMR’s stock symbol?

    The ticker symbol for SyntheticMR is SYNT.

  • What is the current stock price of SyntheticMR?

    As of 17-May-2024 the stock price of SyntheticMR is $2.61.

  • What is the current market cap of SyntheticMR?

    The current market capitalization of SyntheticMR is $109M.

  • What is SyntheticMR’s current revenue?

    The trailing twelve month revenue for SyntheticMR is $8.39M.

  • What is SyntheticMR’s annual earnings per share (EPS)?

    SyntheticMR’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »